1. Home
  2. LTRN vs BAFN Comparison

LTRN vs BAFN Comparison

Compare LTRN & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.75

Market Cap

49.9M

Sector

Health Care

ML Signal

HOLD

Logo BayFirst Financial Corp.

BAFN

BayFirst Financial Corp.

N/A

Current Price

$8.00

Market Cap

40.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LTRN
BAFN
Founded
2013
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
49.9M
40.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LTRN
BAFN
Price
$3.75
$8.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
75.4K
5.9K
Earning Date
11-12-2025
10-30-2025
Dividend Yield
N/A
2.00%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$58,931,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$6.40
52 Week High
$6.12
$19.75

Technical Indicators

Market Signals
Indicator
LTRN
BAFN
Relative Strength Index (RSI) 53.93 37.72
Support Level $3.34 $8.05
Resistance Level $3.72 $8.07
Average True Range (ATR) 0.29 0.10
MACD 0.07 0.04
Stochastic Oscillator 83.18 24.39

Price Performance

Historical Comparison
LTRN
BAFN

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

Share on Social Networks: